Inqanaba 2A Unyango lomhlaza wemiphunga ngo-2026: Idatha entsha ye-ELCC kwi-Neo-Adjuvant Therapy

iindaba

Iindaba

Inqanaba 2A Unyango lomhlaza wemiphunga ngo-2026: Idatha entsha ye-ELCC kwi-Neo-Adjuvant Therapy

Umxholo wokuqonda iNqanaba le-2A Umhlaza weMiphunga yeSeli engeNcinci ka-2026 i-ELCC Ukuphumelela kwi-Neo-Adjuvant Strategies kuNyango oluJoliswe kwi-Driver-Mutated Stage 2A uMhlaza weLung uHlalutya oluthelekisekayo lwe-Trea...

Unyango lwe-Indolent Lung Cancer ngo-2026: IiProtokholi eziNtsha zoKuphila ixesha elide

Umxholo Ukuqonda Umhlaza Wemiphunga Ongasebenziyo ngo-2026 I-Paradigm Shift: Ukusuka kuTyando olukhawulezileyo ukuya kuLungelo oluSebenzayo oluNcincisayo kwiiKhetho zoTyando eziQhubelekayo eziPhumayo ekuJoliswe kuzo...

Unyango lwe-Inoperable Lung Cancer 2026: I-TIL eNtsha kunye noPhulo oluBispecific

Umxholo I-Paradigm Shift kuNyango oluNgasebenzisekiyo loMhlaza weMiphuphu Ukuqonda i-Tumor-Infiltrating Lymphocyte (TIL) Therapy Bispecific Antibodies: Indlela eNgcono-Embini yokuNxibelela uHlahlelo lwe-Eme...

UNyango lwePrimary Lung Cancer 2026: Izikhokelo ezitsha kunye noNyango lwamva nje

Umxholo Ukuqonda uMhlaza oPhambili weMiphunga kunye neMigangatho yokuHlola ka-2026 eHlaziyiweyo yoNyango lweZikhokelo zoNyango oluNgaluncinci lweSeli eNcinci kwiNtuthuko yoMhlaza wamaLunga kwiSeli encinci kuLawulo loMhlaza wamaLunga aSakhasayo...

Lung Cancer Treatment Surgery 2026: New Neo-Adjuvant Breakthroughs

Umxholo Ukuzivelela koTyando loNyango loMhlaza weLung ngo-2026 Ukuphumelela kwi-Immunotherapy-Isekwe kwi-Neo-Adjuvant Regimens ekuJoliswe kuNyango lwe-Driver-Mutation Positive Patients.

UKhetho oluNcinci lweCell Lung Cancer 2026: I-ADC entsha kunye ne-Immunotherapy Breakthroughs

Umxholo Ukuqonda iMeko yangoku yeeNdlela eziNcinci zoNyango loMhlaza wamaLunga weSeli yokuQala: Imidibaniso ye-Immunotherapy Ukunyuka kwe-Antibody-Drug Conjugates (ADCs) ekuJoliswe kwi-DLL3:...

Ekhaya
Amatyala aqhelekileyo
Malunga Nathi
Qhagamshelana nathi

Nceda usishiyele umyalezo